Recalls & Warnings December 12, 2022 FDA Warns Saffron USA for Promoting Teas to Treat Insomnia, Osteoporosis & Cancer On September 23, 2022, the FDA issued a warning letter to Saffron USA LLC following inspection of the companys website which found statements about its Allergy Blend, Chamomile Tea Petals, Diabetic Support Blend, Orange Blast Tea, and Saffron Loose Tea products to be drug
European laboratories rely on analytically verified peptides such as BPC-157 to ensure consistency across multi-phase research studies
M.KramerM
At a past Phelps Health diabetes support group meeting, Phelps Health Clinical Pharmacy Coordinator Tyler Craft, PharmD, BCPS, answered frequently asked questions about Mounjaro
In order to confirm their subcellular localization, we expressed a collection of twenty-three HA-tagged mouse zDHHCs in N2a cells 36